Subscribe to RSS
DOI: 10.1055/a-2688-7904
Diagnostische Herausforderungen nach Preserflo-Microshunt-Implantation
Diagnostic Challenges Following Preserflo Microshunt ImplantationAuthors
Anamnese
Eine 71-jährige Patientin stellte sich erstmals wegen eines seit 4 Jahren diagnostizierten primären chronischen Offenwinkelglaukoms (PCOWG) links vor, das unter Vierfach-Tropftherapie (Brinzolamid/Brimonidintartrat, Latanoprost und Timolol) unzureichend kontrolliert war. Das rechte Partnerauge war bereits an PCOWG erblindet.
Bekannte Vorerkrankungen waren eine kontrollierte arterielle Hypertonie sowie eine HIV-Infektion mit konsekutiver Enzephalopathie, behandelt mit Dolutegravir/Lamivudin, Vitamin B12, Quetiapin, Citalopram und Mirtazapin.
Publication History
Received: 30 May 2025
Accepted: 20 August 2025
Article published online:
17 October 2025
© 2025. Thieme. All rights reserved.
Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
-
Referenzen
- 1 Beckers HJM, Aptel F, Webers CAB. et al. Safety and Effectiveness of the PRESERFLO® MicroShunt in Primary Open-Angle Glaucoma: Results from a 2-Year Multicenter Study. Ophthalmol Glaucoma 2022; 5: 195-209
- 2 Baker ND, Barnebey HS, Moster MR. et al. Ab-Externo MicroShunt versus Trabeculectomy in Primary Open-Angle Glaucoma. Ophthalmology 2021; 128: 17101721
- 3 Lüke JN. et al. Intraoperative primary partial occlusion of the PreserFlo MicroShunt to prevent initial postoperative hypotony. Int Ophthalmol 2023; 43: 2643-2651
- 4 Varma DK, Belovay GW, Tam DY. et al. Malignant glaucoma after cataract surgery. J Cataract Refract Surg 2014; 40: 1843-1849
- 5 Gizzi C, Costa G, Servadei R. et al. A case of malignant glaucoma following insertion of Preserflo™ MicroShunt. Eur J Ophthalmol 2022; 32: 115-119
- 6 Grzybowski A, Kanclerz P. Acute and chronic fluid misdirection syndrome: pathophysiology and treatment. Graefes Arch Clin Exp Ophthalmol 2018; 256: 135-154
- 7 Zhang Y, Wang S, Lin H. et al. Ocular Characteristics of Pseudophakic Eyes with Malignant Glaucoma. Ophthalmic Res 2023; 66: 1159-1168
- 8 Chandler PA, Grant WM. Mydriatic-cycloplegic treatment in malignant glaucoma. Arch Ophthalmol 1962; 68: 353-359
- 9 Safir M, Hecht I, Sharon T. et al. Application of Nd : YAG laser to the anterior vitreous in malignant glaucoma – a systemic review and meta-analysis. Graefes Arch Clin Exp Ophthalmol 2022; 260: 2981-2990
- 10 Schmidt DC, Kessel L, Pedersen KB. et al. Pars plana vitrectomy combined with hyaloido-zonula-iridectomy in treatment of patients with chronic aqueous misdirection: A systematic literature review and case series. Acta Ophthalmol 2021; 99: 251-259
- 11 Micheletti E, Riva I, Bruttini C. et al. A Case of Delayed-onset Hemorrhagic Choroidal Detachment After PreserFlo Microshunt Implantation in a Glaucoma Patient Under Anticoagulant Therapy. J Glaucoma 2020; 29: e87
